-+ 0.00%
-+ 0.00%
-+ 0.00%

EYEPOINT - PHASE 2 VERONA TRIAL IN DME MET PRIMARY ENDPOINT WITH EXTENDED TIME TO SUPPLEMENTAL INJECTION

Reuters·10/19/2026 11:00:02

Please log in to view news